Lilly Presents Phase 3 Data
Eli Lilly presents phase 3 trial results for diabetes treatments Foundayo and retatrutide at ADA conference, potentially impacting diabetes treatment landscape.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.